FiscalNote Inks $40 Million Deal To Divest Two Non-Core Assets, Reducing Debt And Sharpening Core Focus FiscalNote Holdings, Inc. (NYSE:NOTE) shares are trading higher premarket on Monday after the company disclosed a deal to divest two portfolio companies, Oxford Analytica and Dragonfly, from its Global Intelligence division to Dow Jones, a division of News Corporation (NASDAQ:NWS) for $40 million. The sale reflects FiscalNote's ongoing strategy to concentrate on its core Policy platform. The net proceeds from the sale will allow FiscalNote to return capital, reducing its senior term loan and enhancing its balance sheet. This move simplifies the business, minimizing complexity while boosting productivity, efficiency, and profitability. News Corp anticipates receiving a $4 million tax benefit as part of the transaction. The transaction is expected to close in the first quarter of 2025, pending antitrust clearance in Austria and other customary conditions. Josh Resnik, FiscalNote’s CEO & President, said, “This divestiture enables us to pay down a significant portion of our senior term loan, resulting in a cumulative paydown of more than 60 percent in the past year. Beyond strengthening our financial position, this move will streamline operations, expand Adjusted EBITDA margins, and accelerate our path to positive free cash flow.” Almar Latour, CEO of Dow Jones and Publisher of The Wall Street Journal added, “The additions of Dragonfly and Oxford Analytica to our business will allow us to further support our customers in assessing geopolitical risks, building on the news, data, analysis and convening power we already provide through our Dow Jones Risk & Compliance service and our daily news coverage.” As of December end, News Corp held cash and equivalents of $1.75 billion. Also, FiscalNote announced the engagement of John Lee, former Head of Contracts for Palantir‘s U.S. Government Vertical, as a Senior Strategic Advisor. Price Action: NOTE shares are up 13.3% at $1.585 premarket at the last check Monday. Read Next: Equitable Inks Reinsurance Deal With RGA And Plans To Boost Stake In AllianceBernstein: Details Image sourced from Shutterstock. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? FISCALNOTE HOLDINGS (NOTE): Free Stock Analysis Report This article FiscalNote Inks $40 Million Deal To Divest Two Non-Core Assets, Reducing Debt And Sharpening Core Focus originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
FiscalNote Inks $40 Million Deal To Divest Two Non-Core Assets, Reducing Debt And Sharpening Core Focus
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...